Increased serum levels of interleukin-18 in patients with multiple sclerosis
Ferdinando Nicoletti(University of Catania), A. Reggio(University of Catania), Francesco Patti(University of Catania), Roberto Di Marco(University of Catania), Klaus Bendtzen(Rigshospitalet), Alessandra Nicoletti(University of Catania), E. Reggio(Copenhagen University Hospital), Katia Mangano(University of Catania)
Cited by 108
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495